CDKN2B and lung carcinoma: For instance, Du et al. [46] found that the expression of lncRNA CDKN2B-AS1 and adjacent gene CDKN2A in peripheral blood of patients with IPF was significantly downregulated and activated p53 signaling pathway to promote the formation of lung cancer.